跳至主要内容
临床试验/NCT05198947
NCT05198947已完成不适用

Better Disease Control by Multidrug Regimen in Scabies: A Randomized Controlled Trial

B.P. Koirala Institute of Health Sciences0 个研究点目标入组 212 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
212
主要终点
Pruritus

研究概览

简要总结

Scabies is associated with significant discomfort and social taboo. Existing treatment regimen frequently fails due to lack of patient compliance. We compared single use regimen to existing standard repeat application regimen for treatment of scabies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
5 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing patients
  • Clinical diagnosis of scabies
  • Within the age limits

排除标准

  • Unwilling patients
  • Patients with severe co-morbidities requiring long term medication
  • Pregnant women
  • Patients who don't fulfill the age limit criteria

研究组 & 干预措施

Group 1 Permethrin only

Active Comparator

Standard regimen of permethrin 5% topical application to be repeated after 1 week.

干预措施: Permethrin Lotion 5% (Drug)

Group 2 Permethrin and Ivermectin

Active Comparator

A combination regimen of permethrin 5% topical application with oral ivermectin 200 mcg/kg given on the single day only

干预措施: Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg (Drug)

结局指标

主要结局

Pruritus

时间窗: 1 month

Rate of relief from pruritus assessed using visual analog scale

次要结局

  • Skin lesions(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prajwal Pandey

Assistant Professor

B.P. Koirala Institute of Health Sciences

相似试验